Lv11
30 积分 2025-09-07 加入
Efficacy of CD38 ‐Targeted Therapy in Severe, Multi‐Agent Refractory Immune Thrombocytopenia: A Case Series
28分钟前
待确认
Daratumumab in patients with immune thrombocytopenia: a single-center, open-label, phase 2 trial
45分钟前
已完结
Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series
2个月前
已完结
Daratumumab as a novel treatment option in refractory ITP
2个月前
已完结
The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
2个月前
已完结
Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia
2个月前
已完结
Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
2个月前
已完结
Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy
2个月前
已关闭
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
2个月前
已关闭
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
2个月前
已完结
皖公网安备34019202002308
